- NRIX -1.75%
Nurix Therapeutics, Inc. (NASDAQ:NRIX) is a favorite amongst institutional investors who own 66%
Yahoo Finance · 3 weeks ago
Open | 21.25 |
High | 21.46 |
Low | 20.69 |
Mkt Cap | 1.34B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 21.15 |
52 Wk. Low | 4.22 |
52 Wk. High | 24.38 |
Related stocks
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 12.09M | 60.60% ▼ |
Net Income | -44.55M | - |
Diluted EPS | -0.71 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | -$0.68 | - |
Q2 2024 | -$0.63 | -$0.71 |
Q1 2024 | -$0.80 | -$0.76 |
S&P 500^GSPC | 5,505.00-39.59 (-0.71%) |
Dow 30^DJI | 40,287.53-377.49 (-0.93%) |
Nasdaq^IXIC | 17,726.94-144.28 (-0.81%) |
Bitcoin USDBTC-USD | 67,010.75+0.75% |
Dogecoin USDDOGE-USD | 0.13+6.67% |
XRP USDXRP-USD | 0.59+2.92% |